Citation Impact
Citing Papers
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Shear-induced unfolding triggers adhesion of von Willebrand factor fibers
2007 Standout
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
2009 StandoutNobel
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Multiple Antitumor Mechanisms Downstream of Prophylactic Regulatory T-Cell Depletion
2010 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Heparin-induced thrombocytopenia (HIT)
2006
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting
2010 StandoutNobel
Argatroban Anticoagulation for Heparin-Induced Thrombocytopenia in Elderly Patients
2007
Lyme Disease
1989 Standout
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Heparin-induced thrombocytopenia in the emergency department
2004
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use
2003
Heparin‐induced thrombocytopenia: pathogenesis and management
2003
The β-Thalassemias
1999 Standout
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Evaluation of iron overload
2004
Bivalirudin: a review
2005
Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban
2003
Oral Anticoagulant Therapy
2012 Standout
Iron Overload Cardiomyopathy
2010
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Heparin‐induced thrombocytopenia from venous thromboembolism treatment
2005
Warfarin‐associated multiple digital necrosis complicating heparin‐induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma‐associated thrombotic endocarditis
2003
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
Delayed-Onset Heparin-Induced Thrombocytopenia
2004
Transitioning from Argatroban to Warfarin in Heparin-Induced Thrombocytopenia: An Analysis of Outcomes in Patients with Elevated International Normalized Ratio (INR)
2005
IN FOCUS: Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin
2005
Bivalent direct thrombin inhibitors: hirudin and bivalirudin
2004
Gamma-Ray Resistance of Regulatory CD4+CD25+Foxp3+T Cells in Mice
2009
Thrombosis and ELISA optical density values in hospitalized patients with heparin‐induced thrombocytopenia
2004
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Heparin-Induced Thrombocytopenia
2006 Standout
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
2000
Cerebral Sinovenous Thrombosis in Children
2001 Standout
Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation
2005
Autoimmune heparin‐induced thrombocytopenia
2017
Heparin-Induced Skin Lesions and Other Unusual Sequelae of the Heparin-Induced Thrombocytopenia Syndrome
2005
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia
2006
Sickle-cell disease
2010 Standout
Sickle Cell Disease in a Patient with Sickle Cell Trait and Compound Heterozygosity for Hemoglobin S and Hemoglobin Quebec–Chori
1991
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
SWELL1, a Plasma Membrane Protein, Is an Essential Component of Volume-Regulated Anion Channel
2014 StandoutNobel
Think of HIT
2006
Disseminated Intravascular Coagulation
1999 Standout
Heparin‐induced multi‐electrode aggregometry method for heparin‐induced thrombocytopenia testing: communication from the SSC of the ISTH
2016
Hypernatremia
2000 Standout
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Argatroban
2009
Mechanisms and Significance of Cell Volume Regulation
2007
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery
2003
Biochemistry, Physiology, and Complications of Blood Doping: Facts and Speculation
2006
Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia
2006
Variable hematopoietic responses to acute photons, protons and simulated solar particle event protons.
2008
Limitations of Magnetic Resonance Imaging in Measurement of Hepatic Iron
1997
The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study
2005
Fondaparinux: A potential new therapy for HIT
2005
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
Humoral Response to Disseminated Infection by Mycobacterium avium-Mycobacterium intracellulare in Acquired Immunodeficiency Syndrome and Hairy Cell Leukemia
1985
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in blood
1986
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis After Intraoperative Heparin Anticoagulation
2006
Hypernatremia in Elderly Patients
1987
Transitioning from Argatroban to Warfarin Therapy in Patients with Heparin-induced Thrombocytopenia
2005
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
Cerebral venous thrombosis
2004
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study
2003
Iron-Chelating Therapy and the Treatment of Thalassemia
1997
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Partial amino acid sequence of purified von Willebrand factor–cleaving protease
2001
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency Syndrome
1991 Standout
Myocarditis in β-Thalassemia Major
1995
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Argatroban Therapy for Heparin-Induced Thrombocytopenia in Acutely Ill Patients
2007
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Works of Lawrence Rice being referenced
Danaparoid for heparin‐induced thrombocytopenia: an analysis of treatment failures
2003
Improved quality of life for romiplostim‐treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo‐controlled trials
2008
The Negative Regulation of Red Cell Mass by Neocytolysis: Physiologic and Pathophysiologic Manifestations
2005
Erythropoietin Withdrawal Leads to the Destruction of Young Red Cells at the Endothelial-Macrophage Interface
2004
Argatroban Anticoagulation in Obese Versus Nonobese Patients: Implications for Treating Heparin‐induced Thrombocytopenia
2007
Acute cardiorespiratory collapse from heparin: a consequence of heparin‐induced thrombocytopenia
2004
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry
2009
Neocytolysis: physiological down-regulator of red-cell mass
1997
Argatroban therapy in heparin-induced thrombocytopenia
2008
Heparin-Induced Thrombocytopenia
2004
Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura
1998
The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion
2010
Identification, Diagnosis and Treatment of Heparin-induced Thrombocytopenia and Thrombosis: A Registry of Prolonged Heparin Use and Thrombocytopenia among Hospitalized Patients with and without Cardiovascular Disease
2005
Warfarin-Induced Skin Necrosis and Venous Limb Gangrene in the Setting of Heparin-Induced Thrombocytopenia
2004
Fatal cerebral venous thrombosis as the initial manifestation of the antiphospholipid syndrome
1996
Modulation of red cell mass by neocytolysis in space and on Earth
2000
Intractable Renovascular Hypertension in an Adult Recipient of a Pediatric Cadaveric Renal Transplant
1976
Granulomatous infections complicating hairy cell leukemia
1982
Delayed-Onset Heparin-Induced Thrombocytopenia
2002
Assessment of tissue iron overload by nuclear magnetic resonance imaging
1989
Morbidity of Sickle Cell Trait at High Altitude
1984
Responses to Human CD40 Ligand/Human Interleukin-2 Autologous Cell Vaccine in Patients with B-Cell Chronic Lymphocytic Leukemia
2005
Antibody Inhibitors to von Willebrand Factor Metalloproteinase and Increased Binding of von Willebrand Factor to Platelets in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura
2000
Neocytolysis on Descent from Altitude: A Newly Recognized Mechanism for the Control of Red Cell Mass
2001
Argatroban for Suspected Heparin-Induced Thrombocytopenia: Contemporary Experience at a Large Teaching Hospital
2006
Three Suppressor Systems in Human Blood That Modulate Lymphoproliferation
1979